Search option is now available at TUKO! Feel free to search the content on topics/people you enjoy reading about in the top right corner ;)
Kenya is set to get its first dedicated pharma-ceutical and life sciences manufacturing hub after Apifa Biotech secured grant funding from Swedfund International, Sweden's development finance institution, to finance preparatory studies for a proposed Biopharma Life Sciences Park at Konza Technopolis.
The announcement was made on November 12, marking a significant step towards reducing Kenya's dependence on imported medicines and strengthening local healthcare manufacturing capacity.
The project is structured as a public-private partnership between Apifa Biotech and the Technopolis Development Authority, and received National Treasury approval in April 2026 to proceed to the development phase.
Immaculate Kassait: Former Kenya's Data Commissioner Gets Prestigious Gobal Award
A consortium comprising global real estate and investment advisory firm Jones Lang LaSalle (JLL) and healthcare research and analytics company IQVIA has been selected to carry out the feasibility study, bringing expertise in life sciences strategy, infrastructure development and investment planning.
PAY ATTENTION: TUKO is in WhatsApp Channels now! Subscribe and read news in your favourite messenger.
Swedfund's grant will fund the technical and commercial assessments needed to establish the project's viability and lay the groundwork for attracting long-term private investment.




